Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as novel risk factors for Alzheimer’s Disease
Preprint
Abstract
The genetic component of Alzheimer’s disease (AD) has been mainly assessed using Genome Wide Association Studies (GWAS), which do not capture the risk contributed by rare variants. Here, we compared the gene-based burden of rare damaging variants in exome sequencing data from 32,558 individuals —16,036 AD cases and 16,522 controls— in a two-stage analysis. Next to known genes TREM2, SORL1 and ABCA7 , we observed a significant association of rare, predicted damaging variants in ATP8B4 and ABCA1 with AD risk, and a suggestive signal in ADAM10 . Next to these genes, the rare variant burden in RIN3, CLU, ZCWPW1 and ACE highlighted these genes as potential driver genes in AD-GWAS loci. Rare damaging variants in these genes, and in particular loss-of-function variants, have a large effect on AD-risk, and they are enriched in early onset AD cases. The newly identified AD-associated genes provide additional evidence for a major role for APP-processing, Aβ-aggregation, lipid metabolism and microglial function in AD.Keywords
All Related Versions
- Published version: Nature Genetics, 54 (12), 1786.
This publication has 28 references indexed in Scilit:
- Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing studyThe Lancet Neurology, 2015
- Loss‐of‐function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular diseaseAlzheimer's & Dementia, 2015
- TREM2 Variants in Alzheimer's DiseaseNew England Journal of Medicine, 2013
- Variant ofTREM2Associated with the Risk of Alzheimer's DiseaseNew England Journal of Medicine, 2013
- Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate α-secretase activityHuman Molecular Genetics, 2009
- Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer diseaseJournal of Clinical Investigation, 2008
- Role of Genes and Environments for Explaining Alzheimer DiseaseArchives of General Psychiatry, 2006
- Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 MiceJournal of Biological Chemistry, 2005
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Attributable risk percent in case-control studies.Journal of Epidemiology and Community Health, 1971